https://doi.org/10.4081/gc.2018.7833
New trends in drug treatment of heart failure in old age
Accepted: 16 November 2018
HTML: 75
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Heart failure (HF) is a complex clinical syndrome, with high prevalence in the elderly. The World Heath Organization (WHO) predicts that by 2050 the population aged over 80 years will account around 400 million, reflecting that HF will still represent a major public health concern. Improved management of cardiovascular diseases and HF, together with the increased life expectancy explains, at least in part, the high prevalence of HF especially in the elderly. Beside the canonical therapy for HF failure, including angiotensin converting enzyme inhibitors, angiotensin receptor blockers, beta-blockers and aldosterone antagonists, new potential and promising therapies, such as sacubitril/valsartan, iron deficiency treatment and serelaxine, are emerging also in elderly HF patients. In this review we focus on the classical recommended HF therapy and the possible application of new trends in elderly.
How to Cite
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Lorenzo Palleschi, Eleonora Nunziata, Iron deficiency and iron deficiency anaemia in elderly patients with chronic heart failure , Geriatric Care: Vol. 3 No. 4 (2017)
- Francesco Cacciatore, Carlo Gaudiosi, Francesca Mazzella, Anna Scognamiglio, Irene Mattucci, Mauro Carone, Nicola Ferrara, Pasquale Abete, Pneumonia and hospitalizations in the elderly , Geriatric Care: Vol. 3 No. 1 (2017)
- Rita Vieira Alves, Marília Fernandes, Inês Figueiredo, Diogo Drummond Borges, Filipa Louenço, Readmissions in elderly patients with heart failure. A retrospective study , Geriatric Care: Vol. 6 No. 3 (2020)
- Filippo Luca Fimognari, Andrea Corsonello, Alberto Pilotto, Massimo Rizzo, Valentina Bambara, Giovanna Cristiano, Alberto Ferrari, on behalf of the PIACE-SIGOT Study Group Investigators, Community acquired pneumonia in the elderly: the Pneumonia in Italian Acute Care for Elderly units (PIACE) study protocol by the Italian Society of Hospital and Community Geriatrics (SIGOT) , Geriatric Care: Vol. 2 No. 3 (2016)
- Augusto P. Casani, Elena Navari, Dizziness and prevention of falls in the elderly , Geriatric Care: Vol. 3 No. 4 (2017)
- Giuseppe Coppolino, Pierangela Presta, Ramona Nicotera, Giordano Placida, Caterina Vita, Nazareno Carullo, Michele Andreucci, Davide Bolignano, Alberto Castagna, Giovanni Ruotolo, COVID-19 and renal disease in elderly patients , Geriatric Care: Vol. 6 No. 1 (2020)
- Nicola Forni, Valentina Boasi, Katiuscia Sciole, Silvia Borile, Nicoletta Pingelli, Domenico Marra, Sara Tita Farinella, Giovanni Cenderello, Federico Ariel Sanchez, QTc prolongation during the SARS-CoV-2 outbreak: clinical risk management through hospital training course, focus on elderly patients , Geriatric Care: Vol. 6 No. 2 (2020)
- Nicola Vargas, Anna Marro, Hospital territorial integration in the National Recovery and Resilience Plan era: if not now, when? , Geriatric Care: Vol. 9 No. 2 (2023)
- Luca Pellizzari, Camilla Ferronato, Andrea Variola, Martina Setti, Vincenzo Di Francesco, McConnel sign, a simple highly specific sign for identification of a frequent, under diagnosed association: pulmonary embolism and syncope , Geriatric Care: Vol. 7 No. 3 (2021)
- Angelo Di Salvo, The role of association between the cholinergic precursor choline alphoscerate and sulodexide in vascular dementia , Geriatric Care: Vol. 7 No. 3 (2021)
You may also start an advanced similarity search for this article.